These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2175256)

  • 1. A novel tyrosine kinase-independent function of Drosophila abl correlates with proper subcellular localization.
    Henkemeyer M; West SR; Gertler FB; Hoffmann FM
    Cell; 1990 Nov; 63(5):949-60. PubMed ID: 2175256
    [No Abstract]   [Full Text] [Related]  

  • 2. Abl tyrosine kinase in signal transduction and cell-cycle regulation.
    Wang JY
    Curr Opin Genet Dev; 1993 Feb; 3(1):35-43. PubMed ID: 8453272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can clues to the molecular defects in chronic myelogenous leukemia come from genetic studies on the Abelson tyrosine kinase in fruit flies?
    Comer AR; Liebl EC; Hoffmann FM
    J Lab Clin Med; 1995 Jun; 125(6):686-91. PubMed ID: 7769362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosage-sensitive modifiers of Drosophila abl tyrosine kinase function: prospero, a regulator of axonal outgrowth, and disabled, a novel tyrosine kinase substrate.
    Gertler FB; Hill KK; Clark MJ; Hoffmann FM
    Genes Dev; 1993 Mar; 7(3):441-53. PubMed ID: 7680635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of the Drosophila Abelson tyrosine kinase in nerves and muscles: subcellular localization and mutant phenotypes imply a role in cell-cell interactions.
    Bennett RL; Hoffmann FM
    Development; 1992 Dec; 116(4):953-66. PubMed ID: 1295746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic suppression of mutations in the Drosophila abl proto-oncogene homolog.
    Gertler FB; Doctor JS; Hoffmann FM
    Science; 1990 May; 248(4957):857-60. PubMed ID: 2188361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drosophila abl and genetic redundancy in signal transduction.
    Hoffmann FM
    Trends Genet; 1991; 7(11-12):351-5. PubMed ID: 1820686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA.
    Kipreos ET; Wang JY
    Science; 1992 Apr; 256(5055):382-5. PubMed ID: 1566087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation inhibits the interaction of DNA binding proteins with a potential c-abl intron regulatory element.
    Hengst-Zhang JA; Weitzman SA
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1515-21. PubMed ID: 1510678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An activating mutation in the ATP binding site of the ABL kinase domain.
    Allen PB; Wiedemann LM
    J Biol Chem; 1996 Aug; 271(32):19585-91. PubMed ID: 8702653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for Abl in Notch signaling.
    Giniger E
    Neuron; 1998 Apr; 20(4):667-81. PubMed ID: 9581760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The capable ABL: what is its biological function?
    Wang JY
    Mol Cell Biol; 2014 Apr; 34(7):1188-97. PubMed ID: 24421390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK-STAT signaling activated by Abl oncogenes.
    Danial NN; Rothman P
    Oncogene; 2000 May; 19(21):2523-31. PubMed ID: 10851051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic interactions between the Drosophila Abelson (Abl) tyrosine kinase and failed axon connections (fax), a novel protein in axon bundles.
    Hill KK; Bedian V; Juang JL; Hoffmann FM
    Genetics; 1995 Oct; 141(2):595-606. PubMed ID: 8647396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
    Jackson PK; Paskind M; Baltimore D
    Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertilization promotes selective association of the Abl [correction of AbI] kinase with the egg cytoskeleton.
    Walker G; Burgess D; Kinsey WH
    Eur J Cell Biol; 1996 Jun; 70(2):165-71. PubMed ID: 8793389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
    Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. enabled, a dosage-sensitive suppressor of mutations in the Drosophila Abl tyrosine kinase, encodes an Abl substrate with SH3 domain-binding properties.
    Gertler FB; Comer AR; Juang JL; Ahern SM; Clark MJ; Liebl EC; Hoffmann FM
    Genes Dev; 1995 Mar; 9(5):521-33. PubMed ID: 7535279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context.
    Renshaw MW; Kipreos ET; Albrecht MR; Wang JY
    EMBO J; 1992 Nov; 11(11):3941-51. PubMed ID: 1396587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profilin and the Abl tyrosine kinase are required for motor axon outgrowth in the Drosophila embryo.
    Wills Z; Marr L; Zinn K; Goodman CS; Van Vactor D
    Neuron; 1999 Feb; 22(2):291-9. PubMed ID: 10069335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.